Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02425800 · ClinicalTrials.gov registry record
Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 43
- Enrollment target
NCT02425800 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 43 participants.
The verdict
NCT02425800 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
This pilot research trial studies the use of a human prostate tissue model to maintain and study prostate cancer stem cells. A human prostate tissue model uses leftover tissue that was removed during surgery from patients with non-cancerous enlargement of the prostate (benign prostatic hyperplasia) and may create an environment similar to the natural environment of the human body. Prostate cancer stem cells are cells that cause cancer to grow. Using real tissue to create an environment to study stem cells may help doctors learn more about how they work and how they respond to treatments.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Cytology Specimen Collection Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2015-07-28 |
| Est. Completion | 2021-08-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02425800
The ClinicalTrials.gov registry entry for NCT02425800 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT02425800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02425800 about?
NCT02425800 is a clinical study titled "Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells". This pilot research trial studies the use of a human prostate tissue model to maintain and study prostate cancer stem cells. A human prostate tissue model uses leftover tissue that was removed during surgery from patients with non-cancerous enlargement of the prostate (benign prostatic hyperplasia) ...
What is the current status of trial NCT02425800?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2015-07-28. Estimated completion is 2021-08-03.
What interventions are being tested in trial NCT02425800?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Cytology Specimen Collection Procedure (OTHER).
Who is sponsoring clinical trial NCT02425800?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.